Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic lowers Alzheimer’s risk
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to lower risks of Alzheimer's disease in people with type 2 diabetes.
Ozempic lowers Alzheimer’s risk: Research
The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer’s disease among people with type 2 diabetes, according to a new study published Thursday. Alzheimer’s
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.
3h
on MSN
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist ...
23h
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...
studyfinds
4h
Ozempic for Alzheimer’s disease? Popular weight loss drug may also protect the brain
Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.
5h
on MSN
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Alzheimer's disease
Food and Drug Administration
Novo Nordisk
Wegovy
Semaglutide
Feedback